Back

The Rab5 effector Rabankyrin-5 mediates endosomal fusion and trafficking of Human Papillomavirus during early entry

Love, M.; Xie, J.; Zhang, P.

2025-08-05 microbiology
10.1101/2025.08.05.668525 bioRxiv
Show abstract

The fusion of newly formed early endosomal vesicles after endocytosis is a crucial step in viral infection. It facilitates the transition of many viruses from viral internalization to downstream intracellular trafficking within the endosomal network, ultimately enabling their delivery to intracellular replication sites. Despite its significance, the molecular mechanisms regulating the fusion of these vesicles remain poorly understood. In this study, we show that Rabankyrin-5, a Rab5 effector, is essential for the fusion of human papillomavirus (HPV)-containing early endosomes during viral entry. Additionally, Rabankyrin-5 acts as a dynein adaptor, directly binding both the HPV minor capsid protein L2 and the dynein motor complex to link virus-carrying early endosomes to the dynein transport machinery, thereby promoting virus movement along microtubules. These dual functions enable the coordinated integration of endosomal fusion with microtubule-based transport during the early stages of viral entry.

Published in Proceedings of the National Academy of Sciences (predicted rank #3) · training set

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.